temozolomide (low-dose)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for temozolomide (low-dose), covering 2021-09-09 to 2021-09-09. Get the full timeline:
Most recent: Clinical Trial Update: Study on Low Dose Temozolomide Plus Metformin or Placebo in Patient With Recurrent or Refractory Glioblastoma [Phase 2]